The Molecular Anatomy of Human Hsp60 and its Similarity with that of Bacterial Orthologs and Acetylcholine Receptor Reveal a Potential Pathogenetic Role of Anti-Chaperonin Immunity in Myasthenia Gravis
Heat-shock protein 60 (Hsp60) is ubiquitous and highly conserved being present in eukaryotes and prokaryotes, including pathogens. This chaperonin, although typically a mitochondrial protein, can also be found in other intracellular sites, extracellularly, and in circulation. Thus, it can signal the immune system and participate in the development of inflammation and immune reactions. Both phenomena can be elicited by human and foreign Hsp60 (e.g., bacterial GroEL), when released into the blood by infectious agents. Consequently, all these Hsp60 proteins become part of a complex autoimmune response characterized by multiple cross reactions because of their structural similarities. In this study, we demonstrate that Hsp60 proteins from humans and two common pathogens, Chlamydia trachomatis and Chlamydia pneumoniae, share various sequence segments of potentially highly immunogenic epitopes with acetylcholine receptor α1 subunit (AChRα1). The structural data indicate that AChRα1 antibodies, implicated in the pathogenesis of myasthenia gravis, could very well be elicited and/or maintained by self- and/or bacterial Hsp60.
This is a preview of subscription content, log in to check access.
This study was partially supported by the University of Palermo Italy (FC and GZ), and the Istituto Euro-Mediterraneo di Scienza e Tecnologia, Palermo, Italy (FC and AJLM).
Arias HR (2000) Localization of agonist and competitive antagonist binding sites and nicotinic acetylcholine receptors. Neurochem Int 36:595–645PubMedCrossRefGoogle Scholar
Brejc K, Van Dijk WJ, Klaassen RV, Schuurmans M, van Der Oost J, Smit AB, Sixma TK (2001) Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors. Nature 411:269–276PubMedCrossRefGoogle Scholar
Campanella C, Marino Gammazza A, Mularoni L, Cappello F, Zummo G, Di Felice V (2009) A comparative analysis of the products of GROEL-1 gene from Chlamydia trachomatis serovar D and the HSP60 var1 transcript from Homo sapiens suggests a possible autoimmune response. Int J Immunogenet 36:73–78PubMedCrossRefGoogle Scholar
Cappello F, Conway de Macario E, Di Felice V, Zummo G, Macario AJL (2009) Chlamydia trachomatis infection and anti-Hsp60 immunity: the two sides of the coin. PLoS Pathog 5(8):e1000552PubMedCrossRefGoogle Scholar
Cappello F, Marino Gammazza A, Zummo L, Conway de Macario E, Macario AJL (2010) Hsp60 and AChR cross-reactivity in myasthenia gravis: an update. J Neurol Sci 292:117–118PubMedCrossRefGoogle Scholar
Deitiker P, Ashizawa T, Atassi MZ (2000) Antigen mimicry in autoimmune disease. Can immune responses to microbial antigens that mimic acetylcholine receptor act as initial triggers of myasthenia gravis? Hum Immunol 61:255–265PubMedCrossRefGoogle Scholar
Ellis RJ (2007) Protein misassembly: macromolecular crowding and molecular chaperones. Adv Exp Med Biol 594:1–13PubMedCrossRefGoogle Scholar
Henderson B (2010) Integrating the cell stress response: a new view of molecular chaperones as immunological and physiological homeostatic regulators. Cell Biochem Funct 28:1–14PubMedCrossRefGoogle Scholar
Hohlfeld R, Wekerle H (2008) Reflections on the “intrathymic pathogenesis” of myasthenia gravis. J Neuroimmunol 201–202:21–27PubMedCrossRefGoogle Scholar
Horwich AL, Fenton WA, Chapman E, Farr GW (2007) Two families of chaperonin: physiology and mechanism. Annu Rev Cell Dev Biol 23:115–145PubMedCrossRefGoogle Scholar
Le Panse R, Cizeron-Clairac G, Cuvelier M, Truffault F, Bismuth J, Nancy P, De Rosbo NK, Berrih-Aknin S (2008) Regulatory and pathogenic mechanisms in human autoimmune myasthenia gravis. Ann N Y Acad Sci 1132:135–142PubMedCrossRefGoogle Scholar
Lindstrom J, Luo J, Kuryatov A (2008) Myasthenia gravis and the tops and bottoms of AChRs: antigenic structure of the MIR and specific immunosuppression of EAMG using AChR cytoplasmic domains. Ann N Y Acad Sci 1132:29–41PubMedCrossRefGoogle Scholar
Luo J, Taylor P, Losen M, de Baets MH, Shelton GD, Lindstrom J (2009) Main immunogenic region structure promotes binding of conformation-dependent myasthenia gravis autoantibodies, nicotinic acetylcholine receptor conformation maturation, and agonist sensitivity. J Neurosci 29:13898–13908PubMedCrossRefGoogle Scholar
Macario AJL, Lange M, Ahring BK, Conway de Macario E (1999) Stress genes and proteins in the archaea. Microbiol Mol Biol Rev 63:923–967PubMedGoogle Scholar
Macario AJL, Cappello F, Zummo G, Conway de Macario E (2010) Chaperonopathies of senescence and the scrambling of interactions between the chaperoning and the immune systems. Ann N Y Acad Sci 1197:85–93PubMedCrossRefGoogle Scholar
Moiola L, Galbiati F, Martino G, Amadio S, Brambilla E, Comi G, Vincent A, Grimaldi LM, Adorini L (1998) IL-12 is involved in the induction of experimental autoimmune myasthenia gravis, an antibody-mediated disease. Eur J Immunol 28:2487–2497PubMedCrossRefGoogle Scholar